1991
DOI: 10.1159/000200708
|View full text |Cite
|
Sign up to set email alerts
|

Role of Cholecystokinin, Gastrin and Gastrin-Releasing Peptide in the Regulation of Pancreatic Secretion in Cats

Abstract: This study performed on 6 conscious cats with chronic pancreatic fistulas was designed to determine the role of cholecystokinin (CCK), gastrin and gastrin-releasing peptide (GRP) in stimulation of pancreatic secretion in this species. Pancreatic response to GRP infused intravenously in graded doses appears to be mediated predominantly by CCK because a CCK receptor antagonist, L-364,718, abolished this response. Also, gastrin appears to mediate in part the secretory response to GRP because blockade of gastrin r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…This proposal was made because Bn- related peptides and/or activation of BnRs has been shown to play an important role in various inflammatory processes. Evidence supports a role for Bn related peptides and their receptors in a wide spectrum of inflammatory processes including gastritis [263,264,266,288], uveitis [260,264,266], arthritis [98,100,10,251,252,264,266], small intestinal or colonic inflammation [5,12,104,264,266], experimental sepsis [52,61,264,266,267], acute lung inflammation and injury [59,65,264,266,266,341] and gastrointestinal inflammation [10,151,264,266]. These studies suggest BnRs plays different roles in these processes because in some inflammatory processes Bn/GRP is protective and ameliorates the damage from various noxious agents in the stomach, small intestine and in the colon [5,9,12,104,264,266,284], whereas in other inflammatory conditions of the colon or lung, either Bn/GRP stimulate the inflammation or Bn/GRP antagonists ameliorate the inflammation [59,62,65,260,264,266,341,382].…”
Section: Bnr Function In Disease and A Therapeutic Target (Table 3)mentioning
confidence: 99%
“…This proposal was made because Bn- related peptides and/or activation of BnRs has been shown to play an important role in various inflammatory processes. Evidence supports a role for Bn related peptides and their receptors in a wide spectrum of inflammatory processes including gastritis [263,264,266,288], uveitis [260,264,266], arthritis [98,100,10,251,252,264,266], small intestinal or colonic inflammation [5,12,104,264,266], experimental sepsis [52,61,264,266,267], acute lung inflammation and injury [59,65,264,266,266,341] and gastrointestinal inflammation [10,151,264,266]. These studies suggest BnRs plays different roles in these processes because in some inflammatory processes Bn/GRP is protective and ameliorates the damage from various noxious agents in the stomach, small intestine and in the colon [5,9,12,104,264,266,284], whereas in other inflammatory conditions of the colon or lung, either Bn/GRP stimulate the inflammation or Bn/GRP antagonists ameliorate the inflammation [59,62,65,260,264,266,341,382].…”
Section: Bnr Function In Disease and A Therapeutic Target (Table 3)mentioning
confidence: 99%